AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2009
Jul 31, 2009
35134_dirs_2009-07-31_ae398f88-cc0f-40cb-a3b3-b52dc833d258.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2009-07-27
Reporting Person: MASTROPIETRO DONALD R (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 684684 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16